The present invention relates to compositions comprising one or more plant- or fungus-derived compounds and their use for treating or preventing viral respiratory infections (VRIs), such as COVID-19.

Nutraceutical formulations, which could be used for scalp and hair care purposes, with enhanced organoleptie properties have elements of biological origin more particularly a herbal formulation(s).

Nutraceutical formulations, which could be used for scalp and hair care purposes, with enhanced organoleptie properties have elements of biological origin more particularly a herbal formulation(s).

The present invention relates to a composition which is for preventing or treating caffeine abuse and includes evodiamine or Evodia officinalis extract. More specifically, the present invention relates to a pharmaceutical composition which has an effect of preventing or alleviating somnipathy and central nervous system excitation caused by caffeine. In addition, the present invention relates to a caffeine abuse treatment method and a health functional food composition including Evodia officinalis extract or evodiamine.

The present invention relates to a composition which is for preventing or treating caffeine abuse and includes evodiamine or Evodia officinalis extract. More specifically, the present invention relates to a pharmaceutical composition which has an effect of preventing or alleviating somnipathy and central nervous system excitation caused by caffeine. In addition, the present invention relates to a caffeine abuse treatment method and a health functional food composition including Evodia officinalis extract or evodiamine.

The present invention is a diffusional patch having an oil mixture (20) providing mechanical treatment support by reducing the edema in volume and in mass by throwing out the liquid inside by means of diffusion effect after entering into the region with edema by means of the diffusion effect and placed into a porous sheath (10) in microfiber structure, in order to be used in treatment of region with edema which may occur in sports injuries and/or disc hernia (50); characterized in that said oil mixture (20), of which the ingredient proportions in weight are given, comprises the below mentioned ingredients and does not comprise water: Ingredient Amount (%) Dextrin Palmitate Derivatives 1-10 Paraffin 1-30 Oleum nigellae sativae (black cumin oil) 0-20 Oleum origani (carvacrol) 0-20 Oleum lauri expressum (laurel oil) 0-30 Oleum chamomillae (chamomile oil) 0-30 Balsamum meccae (balsam oil) 0-30 Styrax liguidus (sweetgum) 0-30 Oleum limonis (lemon oil) 0-10 Oleum rosmarini (rosemary oil) 0-10 Olive oil 0-30 Oleum vitis vinifera 0-10.

The present invention is a diffusional patch having an oil mixture (20) providing mechanical treatment support by reducing the edema in volume and in mass by throwing out the liquid inside by means of diffusion effect after entering into the region with edema by means of the diffusion effect and placed into a porous sheath (10) in microfiber structure, in order to be used in treatment of region with edema which may occur in sports injuries and/or disc hernia (50); characterized in that said oil mixture (20), of which the ingredient proportions in weight are given, comprises the below mentioned ingredients and does not comprise water: Ingredient Amount (%) Dextrin Palmitate Derivatives 1-10 Paraffin 1-30 Oleum nigellae sativae (black cumin oil) 0-20 Oleum origani (carvacrol) 0-20 Oleum lauri expressum (laurel oil) 0-30 Oleum chamomillae (chamomile oil) 0-30 Balsamum meccae (balsam oil) 0-30 Styrax liguidus (sweetgum) 0-30 Oleum limonis (lemon oil) 0-10 Oleum rosmarini (rosemary oil) 0-10 Olive oil 0-30 Oleum vitis vinifera 0-10.

The present invention is a diffusional patch having an oil mixture (20) providing mechanical treatment support by reducing the edema in volume and in mass by throwing out the liquid inside by means of diffusion effect after entering into the region with edema by means of the diffusion effect and placed into a porous sheath (10) in microfiber structure, in order to be used in treatment of region with edema which may occur in sports injuries and/or disc hernia (50); characterized in that said oil mixture (20), of which the ingredient proportions in weight are given, comprises the below mentioned ingredients and does not comprise water: Ingredient Amount (%) Dextrin Palmitate Derivatives 1-10 Paraffin 1-30 Oleum nigellae sativae (black cumin oil) 0-20 Oleum origani (carvacrol) 0-20 Oleum lauri expressum (laurel oil) 0-30 Oleum chamomillae (chamomile oil) 0-30 Balsamum meccae (balsam oil) 0-30 Styrax liguidus (sweetgum) 0-30 Oleum limonis (lemon oil) 0-10 Oleum rosmarini (rosemary oil) 0-10 Olive oil 0-30 Oleum vitis vinifera 0-10.

The present invention relates to a pharmaceutical composition for preventing or treating ovotoxicity, and more specifically, to a pharmaceutical composition for preventing or treating ovotoxicity, containing an Evodia rutaecarpa Bentham extract. According to the present invention, the Evodia rutaecarpa Bentham extract concentration-dependently increases DPPH free radical scavenging activity so as to have excellent antioxidant activity, inhibits apoptosis of ovarian cells, and activates a PI3K/Akt signaling pathway so as to have a significant protective effect against ovotoxicity to be caused by 4-vinylcyclohexene diepoxide (VCD), thereby being usable as a medicine and a health functional food, which are useful for alleviating, preventing, inhibiting or treating ovotoxicity, premature ovarian failure and the like. Therefore, subfertility treatment or prevention, premature ovarian failure, a menopausal disorder in the premenopausal period, and the like can be considered application examples related thereto.

The present invention relates to a pharmaceutical composition for preventing or treating ovotoxicity, and more specifically, to a pharmaceutical composition for preventing or treating ovotoxicity, containing an Evodia rutaecarpa Bentham extract. According to the present invention, the Evodia rutaecarpa Bentham extract concentration-dependently increases DPPH free radical scavenging activity so as to have excellent antioxidant activity, inhibits apoptosis of ovarian cells, and activates a PI3K/Akt signaling pathway so as to have a significant protective effect against ovotoxicity to be caused by 4-vinylcyclohexene diepoxide (VCD), thereby being usable as a medicine and a health functional food, which are useful for alleviating, preventing, inhibiting or treating ovotoxicity, premature ovarian failure and the like. Therefore, subfertility treatment or prevention, premature ovarian failure, a menopausal disorder in the premenopausal period, and the like can be considered application examples related thereto.